Eazemyapi
API連携 · 4.5K 月間訪問数
Eazemyapiは、創業者、開発者、スタートアップが安全でスケーラブルなバックエンドAPIを数分で作成し、AIモデルを統合できるノーコードプラットフォームです。手動でのデータベース設定や反復的なコーディングの必要性を排除し、迅速な製品開発と展開を可能にします。
製品概要
Eazemyapi 製品概要
Eazemyapiは、創業者、開発者、スタートアップが安全でスケーラブルなバックエンドAPIを数分で作成し、AIモデルを統合できるノーコードプラットフォームです。手動でのデータベース設定や反復的なコーディングの必要性を排除し、迅速な製品開発と展開を可能にします。
Preview
Oomol 製品概要
Oomolは、ユーザーがコードスニペットとAPIを視覚的に接続できるAIプログラマブルワークフロープラットフォームです。ドラッグ＆ドロップインターフェースとプロフェッショナルなコードエディタを組み合わせ、統一されたコンテナ化環境でデータサイエンスやマルチメディア処理などのタスクを迅速に開発・自動化します。
Preview
Detailed feature comparison
| Feature | Eazemyapi | Oomol |
|---|---|---|
| 主要カテゴリー | API連携 | ローコード・ノーコード |
| 追加日 | 2025-11-15 | 2025-08-02 |
| 価格 | フリーミアム | フリーミアム |
| 公式サイト | www.eazemyapi.com | oomol.com |
| 製品タイプ | ウェブサイト | アプリ |
| Performance data | ||
| ユーザー評価 | 未確認 | 未確認 |
| コメント | 0 | 0 |
| 月間訪問数 | 4.5K | 32.8K |
| 月間成長率 | 未確認 | -31.2% |
| お気に入り | 134 | 119 |
| Details | 詳細を見る | 詳細を見る |
Eazemyapi vs Oomol monthly traffic
Compare Eazemyapi and Oomol by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the Eazemyapi vs Oomol monthly traffic comparison, Eazemyapi currently shows 4.5K visits and Oomol shows 32.8K; Oomol has about 7.3 times the visible traffic of Eazemyapi, an absolute difference of about 28.3K visits. This reflects visible reach, not feature quality or paid users.
Only Oomol has complete third-party traffic details; Eazemyapi uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
Oomol is registered at the oomol.com/zh-CN subpage. Because the current data does not state whether other host pages are excluded, treat this as domain-level context rather than independent traffic for one product or project.
Eazemyapi monthly traffic:
Latest traffic
月間訪問数
4.5K
Oomol monthly traffic:
Latest traffic
月間訪問数
32.8K
平均滞在時間
2:00
訪問あたりページ数
3.03
直帰率
36.89%
Data updated 2026-06-15
Monthly traffic trend
- 2026/1: 32K 月間訪問数
- 2026/2: 17.3K 月間訪問数
- 2026/3: 21.7K 月間訪問数
- 2026/4: 47.7K 月間訪問数
- 2026/5: 32.8K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇨🇳China | 87.7% | 28.8K |
| 🇩🇪Germany | 3.51% | 1.2K |
| 🇮🇳India | 2.97% | 975 |
| 🇮🇩Indonesia | 2.96% | 971 |
| 🇺🇸United States | 2.86% | 939 |
流入元
| Source type | Percentage | Traffic |
|---|---|---|
| 参照元 | 53.19% | 17.5K |
| ダイレクト | 46.12% | 15.1K |
| Eメール | 0.69% | 226 |
検索キーワード
craft epubdoubao ttsoomolpdfcraftpdf to epub, ocr to text
Traffic-based selection guidance: Oomol is registered under a oomol.com subpath, so its large visible total may include the host platform. The current data does not justify choosing Oomol for traffic alone; shortlist by unique taxonomy and use case, then validate with the same tasks.
Usage comparison
Compare the core capabilities of Eazemyapi and Oomol
Eazemyapi Core features
API連携
データベースツール
API開発
バックエンド開発
Oomol Core features
ローコード・ノーコード
自動化
ビデオ編集
Use cases
Eazemyapi Use cases
AI連携
データサイエンス
ノーコード
APIビルダー
AWS RDS
バックエンド開発
クラウドホスティング
信用ベースの価格設定
データベース
ラピッドプロトタイピング
スケーラブルなAPI
視覚開発
Oomol Use cases
AI連携
データサイエンス
ノーコード
API連携
自動化プラットフォーム
開発者ツール
JavaScript
ローコード
マルチメディア処理
Python
ビジュアルプログラミング
ワークフロー自動化
Best suited roles
Eazemyapi Best suited roles
データサイエンティスト
起業家たち
創業者
フリーランサー
フロントエンド開発者
プロダクトマネージャー
ソフトウェア開発者
Oomol Best suited roles
確認済みデータなし
Eazemyapi vs Oomol：In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth Eazemyapi vs Oomol comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Eazemyapi is primarily listed under “API連携”, while Oomol is primarily listed under “ローコード・ノーコード”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Eazemyapi: API連携; Oomol: ローコード・ノーコード); Product type (Eazemyapi: Website; Oomol: App); Monthly visits (Eazemyapi: 4.5K; Oomol: 32.8K); Favorites (Eazemyapi: 134; Oomol: 119); Website (Eazemyapi: www.eazemyapi.com; Oomol: oomol.com). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the Eazemyapi vs Oomol monthly traffic comparison, Eazemyapi currently shows 4.5K visits and Oomol shows 32.8K; Oomol has about 7.3 times the visible traffic of Eazemyapi, an absolute difference of about 28.3K visits. This reflects visible reach, not feature quality or paid users.
Only Oomol has complete third-party traffic details; Eazemyapi uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
Oomol is registered at the oomol.com/zh-CN subpage. Because the current data does not state whether other host pages are excluded, treat this as domain-level context rather than independent traffic for one product or project.
Oomol is registered under a oomol.com subpath, so its large visible total may include the host platform. The current data does not justify choosing Oomol for traffic alone; shortlist by unique taxonomy and use case, then validate with the same tasks.
Product positioning, use cases, and roles
Eazemyapi and Oomol currently overlap in shared tags: AI連携、データサイエンス、ノーコード. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Eazemyapi's unique categories/tags are API連携、データベースツール、API開発、バックエンド開発、APIビルダー、AWS RDS、クラウドホスティング、信用ベースの価格設定; Oomol's are ローコード・ノーコード、自動化、ビデオ編集、API連携、自動化プラットフォーム、開発者ツール、JavaScript、ローコード. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
Eazemyapi has no verified rating, 0 comments, 134 favorites, and 136 likes；Oomol has no verified rating, 0 comments, 119 favorites, and 117 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate Eazemyapi first
Put Eazemyapi on the priority trial list when the task aligns with “API連携” and especially API連携、データベースツール、API開発、バックエンド開発、APIビルダー、AWS RDS, or the users include データサイエンティスト、起業家たち、創業者、フリーランサー. This follows recorded positioning and does not imply unlisted capabilities are absent.
Eazemyapi also currently records: pricing is freemium, product type is website, 4.5K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Oomol first
Put Oomol on the priority trial list when the task aligns with “ローコード・ノーコード” and especially ローコード・ノーコード、自動化、ビデオ編集、API連携、自動化プラットフォーム、開発者ツール. This follows recorded positioning and does not imply unlisted capabilities are absent.
Oomol also currently records: pricing is freemium, product type is app, 32.8K monthly visits shown for the registered host (subpage scope unknown), no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Eazemyapi and Oomol, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
比較 FAQ
How should I choose between Eazemyapi and Oomol?
Compare positioning, pricing, taxonomy, and traffic maturity, then verify the latest details on each official website.
Where does this comparison data come from?
The factual baseline is derived from product, taxonomy, traffic, and community data. Reviewed editorial conclusions show their source and verification date.
What do unknown fields mean?
Unknown means there is not enough reliable evidence; the page does not fill gaps with assumptions.